For research use only. Not for human or veterinary use.Free Next Day UK Delivery on orders over £100
Analytically VerifiedVial of KLOW Peptide Blend (80mg)
← Back to Catalogue

KLOW Peptide Blend (80mg)

KLOW Peptide Blend Reference Standard

£85.00 ex. VAT

12 researchers are currently viewing this protocol
High Demand: Only 20 vials remain in current verified batch
Low Stock: Only 0 vials remaining in current synthesis batch

Dispatched on dry ice. Institutional PO accepted at checkout.

Verified Purity≥99% HPLC
Secure TransitTracked UK Delivery
ExpeditedSame-Day Dispatch
Certificate of Analysis

HPLC/MS Data Available

Print Certificate of Analysis →
Safety Data Sheet (SDS)

Handling and safety information

Request SDS →

Research Overview

A synergistic blend formulated for evaluating complex inflammatory modulation alongside extracellular matrix remodeling.

Pathways:Anti-InflammatoryECM RemodelingTissue Repair

Scientific Specifications

CAS NumberMixture
Molecular Formula
Molecular WeightUnverified
Sequence
Chemical FormUnknown
AppearanceBlue lyophilised powder
Solubility
Storage (Unopened)
Handling Notes
  • Contains 10mg KPV, 10mg GHK-Cu, 50mg BPC-157, and 10mg TB-500 per vial.

Literature & Citations

Independent peer-reviewed literature investigating KLOW Peptide Blend. Purivo Biolabs supplies this compound strictly for in-vitro replication of these studies.

Clinical Literature & FAQ

Frequently Asked Questions

How should KLOW Peptide Blend (80mg) be stored?

Lyophilized KLOW Peptide Blend (80mg) is stable at room temperature for 90 days, but for long term storage it should be kept at -20°C. Upon reconstitution, it must be refrigerated at 2°C - 8°C and used within 30 days.

What is the typical purity of your reference standard?

Our minimum threshold is >99.0% by HPLC. Specific batch purity is detailed in the accompanying COA.

Research Use Only

This material is supplied strictly for in-vitro laboratory research. It is not for human or veterinary administration. Purivo Biolabs does not hold marketing authorisation and makes no therapeutic claims.